These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17274899)

  • 1. [Clinical and angiographic predictors of restenosis after bare metal stent deployment in coronary artery disease patients complicated with diabetes].
    Jin ZN; Chen YD; Lü SZ; Song XT; Zhu HG; Li H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Dec; 34(12):1093-6. PubMed ID: 17274899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Compare drug-eluting stent to bare-metal stent in prognosis on treating diffuse coronary lesions].
    Qiao SB; Hou Q; Xu B; Chen J; Liu HB; Yang YJ; Wu YJ; Yuan JQ; Wu Y; Dai J; You SJ; Ma WH; Zhang P; Gao Z; Dou KF; Qiu H; Mu CW; Chen JL; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):487-91. PubMed ID: 16842660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients.
    West NE; Ruygrok PN; Disco CM; Webster MW; Lindeboom WK; O'Neill WW; Mercado NF; Serruys PW
    Circulation; 2004 Feb; 109(7):867-73. PubMed ID: 14757691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease.
    Park DW; Hong MK; Suh IW; Hwang ES; Lee SW; Jeong YH; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2007 Mar; 99(6):760-5. PubMed ID: 17350360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of vessel size, lesion length and diabetes mellitus on angiographic restenosis outcomes: insights from the NIRTOP study.
    Kornowski R; Fort S; Almagor Y; Silber S; Lewis BS;
    Acute Card Care; 2008; 10(2):104-10. PubMed ID: 18568572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus.
    Mazeika P; Prasad N; Bui S; Seidelin PH
    Am Heart J; 2003 Jun; 145(6):1013-21. PubMed ID: 12796757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year clinical follow up of coronary drug-eluting stent in patients at high risk for coronary restenosis.
    Azzarelli S; Amico F; Galassi AR; Giacoppo M; Argentino V; Fiscella A
    J Invasive Cardiol; 2008 Feb; 20(2):62-6. PubMed ID: 18252969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
    Stone GW; Ellis SG; Cannon L; Mann JT; Greenberg JD; Spriggs D; O'Shaughnessy CD; DeMaio S; Hall P; Popma JJ; Koglin J; Russell ME;
    JAMA; 2005 Sep; 294(10):1215-23. PubMed ID: 16160130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and angiographic outcome in coronary artery disease patients with type-II diabetes mellitus undergoing elective bare-metal stenting or drug-eluting stenting].
    Qiao SB; Hou Q; Xu B; Chen J; Liu HB; Yang YJ; Wu YJ; Yuan JQ; Wu Y; Dai J; You SJ; Ma WH; Zhang P; Gao Z; Dou KF; Qiu H; Mu CW; Chen JL; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):523-6. PubMed ID: 17711711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.
    Cassese S; Byrne RA; Tada T; Pinieck S; Joner M; Ibrahim T; King LA; Fusaro M; Laugwitz KL; Kastrati A
    Heart; 2014 Jan; 100(2):153-9. PubMed ID: 24270744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents.
    Hoffmann R; Stellbrink E; Schröder J; Grawe A; Vogel G; Blindt R; Kelm M; Radke PW
    Am J Cardiol; 2007 Nov; 100(9):1347-52. PubMed ID: 17950788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
    Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
    Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition from bare metal to drug eluting stenting in contemporary US practice: effect on incidence and predictors of clinically driven target lesion revascularization.
    Jonas M; Resnic FS; Levin AD; Arora N; Rogers CD
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):175-83. PubMed ID: 17630659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vessel caliber and restenosis: a prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient.
    Ruygrok PN; Webster MW; Ardill JJ; Chan CC; Mak KH; Meredith IT; Stewart JT; Ormiston JA; Price S
    Catheter Cardiovasc Interv; 2003 Jun; 59(2):165-71. PubMed ID: 12772233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
    Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
    Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold the promise?
    Jensen J; Lagerqvist B; Aasa M; Särev T; Nilsson T; Tornvall P
    J Intern Med; 2006 Aug; 260(2):118-24. PubMed ID: 16882275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.
    Hong SJ; Kim MH; Ahn TH; Ahn YK; Bae JH; Shim WJ; Ro YM; Lim DS
    Heart; 2006 Aug; 92(8):1119-24. PubMed ID: 16449516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.